B2G Life Sciences – Building Bridges and Gateways

B2G Life Sciences is a consulting company and contract research organisation (CRO) dedicated to the pharmaceutical industry that specialises in clinical development and regulatory affairs. The company capitalises on the experience of its founder Hafedh Haddad, who was former head of clinical development at Genethon. Haddad is a medical doctor and holds a Masters degree in clinical research from the University of Pierre et Marie Curie in Paris. B2G Life Science has comprehensive knowledge of the science industry in both Europe and North Africa, allowing it to assist in the implementation of gateways and interfaces for communication between operators and the medical, scientific and economic potentials in North Africa.